Safety desk
Unknown does not
mean harmless.
FDA is short for Food and Drug Administration, the US drug agency.
A small study can miss a problem. In its review checked on September 28, 2026, FDA said the studies in people could not show whether BPC-157 was safe.
The body’s defence system may react.
An immune reaction is when the body’s defence system treats a substance as an invader.
Impurities are unwanted substances mixed into the material.
In its review checked on September 28, 2026, FDA raised concerns about immune reactions, unwanted substances, and not knowing exactly which ingredient a product contains.
No study in that review had tested whether BPC-157 products caused immune reactions.
FDA described possible reactions ranging from nothing noticeable to harm that could threaten life.
It did not measure how often these reactions happen.
Source · FDA’s immune-reaction reviewThere is no official list of who must avoid it.
As of September 28, 2026, BPC-157 had no FDA-reviewed label listing interactions or guidance for pregnancy.
The human studies FDA reviewed did not include pregnancy.
Source · FDA’s label and study findingsAn interaction is when one substance affects another. Ask the person giving your care about your own medicines and health history.
There is no FDA-reviewed list of BPC-157 interactions to check. That does not mean it can be used without harm alongside other medicines.
A problem report does not prove a cause.
FDA’s search through December 4, 2025, found three reports involving injected BPC-157.
The reports described swelling and redness, breathing trouble, and darkening of the skin and gums.
FDA could not tell whether BPC-157 caused those problems.
Source · FDA’s problem-report reviewThese reports cannot tell how often a problem happens.
Source · FDA’s limits on problem reportsA polished page still needs checking.
The US agency for consumer protection is called the Federal Trade Commission, or FTC.
FTC guidance checked on September 17, 2026, says official-looking seals and refund promises can be faked.
Source · FTC’s health-site guidanceLook up the doctor or pharmacy with the state board that licenses them. Ask about the evidence behind the offer.
A label saying research use only did not mean FDA had checked a BPC-157 product for people, as recorded on September 28, 2026.
Source · FDA’s product approval recordsPatients can add a problem report.
In the FDA guidance checked on September 17, 2026, patients could report medicine problems through MedWatch, its public reporting service.
Source · FDA’s MedWatch serviceKeep the product and care records when asking about a concern. A report adds information; it does not give a care plan.